NÖTROFİL/LENFOSİT VE PLATELET/LENFOSİT ORANLARI AZOOSPERMİ VE ANORMAL SPERM PARAMETRELERİ İÇİN PREDİKTİF MARKER OLARAK KULLANILABİLİR Mİ? Is It Possible to Use Neutrofil/Lymphocyte and Platelet/Lymphocyte Ratio as a Predictive Marker for Azoospermia and Abnormal Semen Parameters?
ÖZET
___
- 1. Jungwirth A, Diemer T, Kopa Z, Krausz C, Minhas S, Tournaye H. Guidelines on Male Infertility (EAU). 2018.
2. Azenabor A, Ekun AO, Akinloye O. Impact of Inflammation on Male Reproductive Tract. J Reprod Infertil. 2015;16(3):123-9.
3. Hamada A, Esteves SC, Nizza M, Agarwal A. Unexplained male infertility: diagnosis and management. Int Braz J Urol 2012;38:576-94.
4. Ilhan G, Atmaca FFV, Altan E, Zebitay AG, Sozen H, Akyol H et al. Evaluation of Neuthrophil-Lymphocyte Ratio, Platelet- Lymphocyte Ratio, Red Blood Cell Distrubution Widht-Platelet Ratio for Diagnosis of Premature Ovarian Insufficiency. Journal of Family and Reproductive Health. 2016;10(4):211-6.
5. Weidner, W, Pilatz, A, Diemer, T, Schuppe, H. C, Rusz, A, Wagenlehner, F. Male urogenital infections: Impact of infection and inflammation on ejaculate parameters. World Journal of Urology 2013;31:717–23.
6. Agarwal A, Saleh RA. Role of oxidants in male infertility: rationale, significance, and treatment. Urol Clin North Am. 2002;29(4):817-27.
7. Güneş M, Umul M, Altok M, Akyuz M, İşoğlu CS, Uruc F, et al. Predictive role of hematologic parameters in testicular torsion. Korean J Urol 2015;56:324–9.
8. Kaya H, Ertas F, Islamoglu Y, Kaya Z, Atılgan ZA, Cil H, et al. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clinical and Applied Thrombosis/Hemostasis 2012;20(1):50–4.
9. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012; 26;5(1):2.
10. Guthrie, GJ, Charles, KA, Roxburgh, CS, Horgan, PG, McMillan, DC, Clarke, SJ. The systemic inflammation‐based neutrophil‐lymphocyte ratio: Experience in patients with cancer. Critical Reviews in Oncology Hematology 2013;88(1):218-30.